Views 201
Citations 0
Invited Critique
March 2013

From TEM to TMEComment on “No-Scar Transanal Total Mesorectal Excision”

Author Affiliations

Author Affiliation: Department of Colorectal Surgery, Beaumont Hospital, Dublin, Ireland.

JAMA Surg. 2013;148(3):231. doi:10.1001/jamasurg.2013.703

Leroy and colleagues1 report their exceptional achievement in providing for a patient with rectal neoplasia an oncologically packaged TME entirely via a pure natural orifice (transanal, transrectal) approach. While the ultimate pathology proved benign (and so meaning that a more conventional intraluminal microsurgical/endoscopic resection would also have conferred a cure in this particular instance), Leroy and colleagues have studiously developed an operative strategy whose realization is more than just a potential additional niche in our therapeutic armamentarium for mid- to low-rectal tumors. Their implicit separation of the mesorectal excision component from the mesocolic lymphadenectomy inherent to the standard transabdominal operation (whatever the access) may also portend an era of stratified resective extent for colorectal cancer individualized by preoperative staging and molecular profiling.

First Page Preview View Large
First page PDF preview
First page PDF preview